Navigation Links
Sophiris Bio to Webcast Live Presentation at BetterInvesting's Virtual Investor Conference

SAN DIEGO and VANCOUVER, British Columbia, Jan. 30, 2017 /PRNewswire/ -- Sophiris Bio Inc. (NASDAQ: SPHS) a biopharmaceutical company developing topsalysin (PRX302) for the treatment of urological diseases, today announced that Randall E. Woods, president and chief executive officer, will present a corporate overview at the BetterInvesting™ Virtual Investor Conference. The presentation will take place on Thursday February 2, 2017 at 1:00 p.m. Eastern Time.

The presentation will be webcast live at and can also be accessed through the Investor Relations page at A replay of the presentation will be available on the Company's website for 90 days.  

Recent Company Highlights

  • In August 2016, Sophiris raised net proceeds of $27.4 million to fund a Phase 2b clinical trial for the treatment of localized prostate cancer and working capital and general corporate purposes.
  • In June 2016, Sophiris completed a Phase 2a proof of concept trial of topsalysin in localized prostate cancer in which topsalysin demonstrated the ability to ablate tumor cells in 50 percent of patients, including two men who experienced complete ablation of their targeted tumor with no evidence of any tumor remaining at 6 months post treatment.
  • In May 2016, Sophiris presented complete results from a Phase 3 BPH study at the AUA 2016 Annual Meeting demonstrating that topsalysin met the primary endpoint of a reduction in symptom score compared to the vehicle control arm.

About Sophiris 
Sophiris Bio Inc. is a biopharmaceutical company developing topsalysin, a clinical-stage, targeted therapy for the treatment of urological diseases. Topsalysin has successfully completed a Phase 2a clinical trial for the treatment of localized low to intermediate risk prostate cancer. Topsalysin has also successfully completed a Phase 3 clinical study for the treatment of the symptoms of benign prostatic hyperplasia (BPH), and is designed to be as efficacious as pharmaceuticals, less invasive than the surgical interventions, and without the sexual side effects seen with existing treatments. For more information, please visit

Since 2010,, created by BetterInvesting (NAIC) and PRNewswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.

Certain statements included in this press release may be considered forward-looking. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on Sophiris' current beliefs as well as assumptions made by and information currently available to Sophiris and relate to, among other things, anticipated financial performance, business prospects, strategies, regulatory developments, market acceptance and future commitments. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by Sophiris in its public securities filings; actual events may differ materially from current expectations. Sophiris disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

To view the original version on PR Newswire, visit:

SOURCE Sophiris Bio Inc
Copyright©2017 PR Newswire.
All rights reserved

Related medicine technology :

1. Sophiris Bio Phase 3 BPH Study Successfully Meets Primary Endpoint
2. Sophiris Bio Reports Third Quarter Financial Results and Business Highlights
3. Sophiris Bio to Present at BIO CEO & Investor Conference
4. Sophiris Bio Reports Third Quarter 2016 Financial Results and Key Business Highlights
5. How These Generic Drugs Stocks are Faring? -- Catalyst Pharma, Sophiris Bio, Momenta Pharma, and Agile Therapeutics
6. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
7. Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd
8. Amgen To Webcast Investor Meeting At Upcoming American Society Of Clinical Oncology Annual Meeting
9. DelMar Pharmaceuticals, Inc. to Webcast, Live, at June 6th
10. HeartWare Presentation At The Goldman Sachs 34th Annual Global Healthcare Conference To Be Webcast
11. Volcano Corporation Presentation At Goldman Sachs Conference To Be Webcast
Post Your Comments:
(Date:11/22/2019)... ... November 22, 2019 , ... Personal Care Management has since its inception provided ... elderly or senior clients. The registered nurses (RN) and licensed vocational nurses (LVN) ... are state licensed to do skilled care and non-medical care (PAS),” said Brenda Jaye, ...
(Date:11/22/2019)... ... November 22, 2019 , ... Get Your CEU has published ... how to obtain a career in radiology. , With this infographic, Get Your CEU ... infographic also provides helpful information on specialties and the career outlook within the field. ...
(Date:11/22/2019)... ... November 22, 2019 , ... ... Charleston, SC utilizing the TeethXpress solution, a revolutionary approach to replacing missing teeth. ... temporary tooth replacement all in one day. Patients who receive the TeethXpress treatment ...
Breaking Medicine Technology:
(Date:11/30/2019)... ... November 28, 2019 , ... ... for its award-winning cannabis cultivation, production and dispensary operations, has received a Clio ... of products. , “This is a great accomplishment for our company and also ...
(Date:11/30/2019)... ATLANTA (PRWEB) , ... November 29, 2019 , ... ... with family gatherings and honored customs, teachers aren’t focusing on the potential for ... students won’t be picking up their textbooks or logging into GoogleClassroom as often ...
(Date:11/27/2019)... ... 2019 , ... NucleusHealth, the medical image management and teleradiology ... sets that allow the system to readily demonstrate cloud PACS functionality on a ... time at the Radiological Society of North America (RSNA) Annual Meeting ...
(Date:11/27/2019)... ... November 27, 2019 , ... ... human sense of smell has a far deeper reach. Aroma travels directly to ... have hugely beneficial effects on both consumers and workers. The human olfactory system ...
(Date:11/27/2019)... ... , ... Autism Live, The Center for Autism and Related Disorders, and We ... special event for children with autism spectrum disorder (ASD). Children who attend the Autism ... wrapped toy, while also getting the opportunity to explore uniquely ASD-friendly gym equipment. ...
Breaking Medicine News(10 mins):